Published by Coherent Market Insights
Posted on September 29, 2021
The Hematology Market has witnessed continuous growth in the past few years and is projected to grow even further during the forecast period (2021-2027). The research presents a complete assessment of the market and contains Future trend, Current Growth Factors, attentive opinions, facts, historical data, and statistically supported and industry validated market data.
Hematology Market report presents the detail analysis of the parent market based on elite players, present, past and futuristic data which will serve as a profitable guide for all the industry competitors. Key players in the Hematology market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All measurement shares, splits, and breakdowns have been resolute using secondary sources and verified primary sources. The Market report begins with a basic overview of the industry lifecycle, definitions, classifications, applications, and industry chain structure and all these together will help leading players understand scope of the Market, what characteristics it offers and how it will fulfill customer’s requirements.
Click Here To Get Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/943
Hematology is the branch of medicine concerned with the study of blood and blood disorders. It helps diagnose, treat, and prevent diseases related to blood. Hematological tests can help diagnose infection, anemia, hemophilia, leukemia, and blood-clotting disorders. It is also used to treat malignancies and types of hemophilia, lymphoma and sickle-cell anemia. There are four major areas of study within hematology, such as hematological malignancies, anemia, coagulopathy, and hemoglobinopathy.
Hematological tests include in vitro diagnostic tests, such as histology, hemostasis, molecular diagnostics, blood examination, and flow cytometry and helps to recognize different blood-related diseases. Moreover, hematology includes issues related to platelets, white blood cells (WBC’s), red blood cells (RBC’s), and organs that are nourished by blood cells, including the spleen, lymph nodes, thymus, and lymphoid tissue. Hematology serves clinicians and scientists around the world who are working to conquer blood diseases.
Key Market Drivers:
Increasing prevalence of blood related disorders across the globe is expected to propel growth of the hematology market during the forecast period. Hemophilia is a rare heredity bleeding disorder that requires treatment for life. For instance, according to the National Hemophilia Foundation, around 3,000 to 33,000 people in the United States are living hemophilia, of which 60% have severe hemophilia, 15% have moderate hemophilia, and 25% have mild hemophilia.
Moreover, introduction of technologically advanced hematology products worldwide is also expected to boost the growth of the hematology market. For instance, in March 2021, Sysmex Corporation announced the launch of its next-gen flagship model in the hematology field, the XR-Series Automated Hematology Analyzer, and a compact 3-part WBC differential model, the XQ-Series Automated Hematology Analyzer. Starting with the launch of these products, Sysmex plans to strengthen its hematology product portfolio to help optimize operations at testing laboratories in line with regional characteristics and facility needs.
COVID-19 Impact Analysis:
The healthcare community was unprepared for the impact of COVID-19 (the global pandemic) and is now gradually learning to live with the pandemic. Some people with COVID-19 develop abnormal blood clots, and scientists are trying to understand why some people develop a blood clot after receiving a COVID vaccine. Having hemoglobin blood disorders, such as thalassemia and sickle cell disease (SCD), can increase a person’s chance of becoming seriously ill with COVID-19, according to CDC. Therefore, the demand for safe and effective treatment of such disorders is increasing, worldwide. This in turn is expected to augment the market growth.
Key Takeaways:
The hematology market is expected to exhibit a CAGR of XX % during the forecast period owing to the emergence of high throughput hematology analyzers worldwide. For instance, in December 2020, Nihon Kohden launched an Automated Hematology and ESR Analyzer, MEK-1305 Celltac α+, in overseas markets. MEK-1305 can measure complete blood count (CBC). MEK-1305 is designed to provide rapid and accurate results, which are important for understanding the clinical condition of patients.
Among regions, North America is expected to witness significant growth in the hematology market, owing to rise in prevalence of blood related disorders and technological advances in hematology, in this region. For instance, according to Centers for Disease Control and Prevention (CDC), Von Willebrand disease is the most common type of bleeding disorder in the United States, affecting up to 1% of the US population or 1 in every 100 people. Moreover, sickle cell disease (SCD) is the most common genetic disorder in the U.S., with about 100,000 American who have the disease and another 2 million who carry the trait.
What Hematology Market report offers:
Major Players Analysed The Market
These Players Are: Abbott Laboratories, Sysmex Co., Beckman Coulter, Horiba, Ltd., Boule Diagnostics AB, Mind ray Medical International Limited, Siemens Healthcare, Roche Diagnostics, Bio Rad laboratories, Sigma Aldrich Co., Nihon Kohden Corporation.
Remarkable Attributes of Hematology Market Report:
Buy This Research Study Report For Quick Access with flat US $ 2000 off@ https://www.coherentmarketinsights.com/promo/buynow/943
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
The post Hematology Market To Witness A Savoury Growth At A CAGR Of 7.80% Between 2021 to 2027. appeared first on Gatorledger.
The Hematology Market has witnessed continuous growth in the past few years and is projected to grow even further during the forecast period (2021-2027). The research presents a complete assessment of the market and contains Future trend, Current Growth Factors, attentive opinions, facts, historical data, and statistically supported and industry validated market data.
Hematology Market report presents the detail analysis of the parent market based on elite players, present, past and futuristic data which will serve as a profitable guide for all the industry competitors. Key players in the Hematology market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All measurement shares, splits, and breakdowns have been resolute using secondary sources and verified primary sources. The Market report begins with a basic overview of the industry lifecycle, definitions, classifications, applications, and industry chain structure and all these together will help leading players understand scope of the Market, what characteristics it offers and how it will fulfill customer’s requirements.
Click Here To Get Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/943
Hematology is the branch of medicine concerned with the study of blood and blood disorders. It helps diagnose, treat, and prevent diseases related to blood. Hematological tests can help diagnose infection, anemia, hemophilia, leukemia, and blood-clotting disorders. It is also used to treat malignancies and types of hemophilia, lymphoma and sickle-cell anemia. There are four major areas of study within hematology, such as hematological malignancies, anemia, coagulopathy, and hemoglobinopathy.
Hematological tests include in vitro diagnostic tests, such as histology, hemostasis, molecular diagnostics, blood examination, and flow cytometry and helps to recognize different blood-related diseases. Moreover, hematology includes issues related to platelets, white blood cells (WBC’s), red blood cells (RBC’s), and organs that are nourished by blood cells, including the spleen, lymph nodes, thymus, and lymphoid tissue. Hematology serves clinicians and scientists around the world who are working to conquer blood diseases.
Key Market Drivers:
Increasing prevalence of blood related disorders across the globe is expected to propel growth of the hematology market during the forecast period. Hemophilia is a rare heredity bleeding disorder that requires treatment for life. For instance, according to the National Hemophilia Foundation, around 3,000 to 33,000 people in the United States are living hemophilia, of which 60% have severe hemophilia, 15% have moderate hemophilia, and 25% have mild hemophilia.
Moreover, introduction of technologically advanced hematology products worldwide is also expected to boost the growth of the hematology market. For instance, in March 2021, Sysmex Corporation announced the launch of its next-gen flagship model in the hematology field, the XR-Series Automated Hematology Analyzer, and a compact 3-part WBC differential model, the XQ-Series Automated Hematology Analyzer. Starting with the launch of these products, Sysmex plans to strengthen its hematology product portfolio to help optimize operations at testing laboratories in line with regional characteristics and facility needs.
COVID-19 Impact Analysis:
The healthcare community was unprepared for the impact of COVID-19 (the global pandemic) and is now gradually learning to live with the pandemic. Some people with COVID-19 develop abnormal blood clots, and scientists are trying to understand why some people develop a blood clot after receiving a COVID vaccine. Having hemoglobin blood disorders, such as thalassemia and sickle cell disease (SCD), can increase a person’s chance of becoming seriously ill with COVID-19, according to CDC. Therefore, the demand for safe and effective treatment of such disorders is increasing, worldwide. This in turn is expected to augment the market growth.
Key Takeaways:
The hematology market is expected to exhibit a CAGR of XX % during the forecast period owing to the emergence of high throughput hematology analyzers worldwide. For instance, in December 2020, Nihon Kohden launched an Automated Hematology and ESR Analyzer, MEK-1305 Celltac α+, in overseas markets. MEK-1305 can measure complete blood count (CBC). MEK-1305 is designed to provide rapid and accurate results, which are important for understanding the clinical condition of patients.
Among regions, North America is expected to witness significant growth in the hematology market, owing to rise in prevalence of blood related disorders and technological advances in hematology, in this region. For instance, according to Centers for Disease Control and Prevention (CDC), Von Willebrand disease is the most common type of bleeding disorder in the United States, affecting up to 1% of the US population or 1 in every 100 people. Moreover, sickle cell disease (SCD) is the most common genetic disorder in the U.S., with about 100,000 American who have the disease and another 2 million who carry the trait.
What Hematology Market report offers:
Major Players Analysed The Market
These Players Are: Abbott Laboratories, Sysmex Co., Beckman Coulter, Horiba, Ltd., Boule Diagnostics AB, Mind ray Medical International Limited, Siemens Healthcare, Roche Diagnostics, Bio Rad laboratories, Sigma Aldrich Co., Nihon Kohden Corporation.
Remarkable Attributes of Hematology Market Report:
Buy This Research Study Report For Quick Access with flat US $ 2000 off@ https://www.coherentmarketinsights.com/promo/buynow/943
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
The post Hematology Market To Witness A Savoury Growth At A CAGR Of 7.80% Between 2021 to 2027. appeared first on Gatorledger.
Explore more articles in the Research Reports category
